Avalo Therapeutics Historical PE Ratio image   This AVTX PE ratio history page last updated 9/28/2023
Avalo Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2023
8/3/2023
0.20-0.59-2.36NA
Q1 2023
5/4/2023
2.82-0.85-3.40NA
Q4 2022
3/29/2023
1.61-1.04-4.16NA
Q3 2022
11/7/2022
6.700.341.364.9
Q2 2022
8/4/2022
4.05-1.38-5.52NA
Q1 2022
5/5/2022
3.96-2.40-9.60NA
Q4 2021
3/2/2022
9.37-1.92-7.68NA
Q3 2021
11/9/2021
27.84-2.04-8.16NA
Q2 2021
8/2/2021
32.28-2.16-8.64NA
Q1 2021
5/13/2021
27.00-3.84-15.36NA
Q4 2020
3/8/2021
36.72-2.28-9.12NA
Q3 2020
11/9/2020
24.72-1.92-7.68NA
Q2 2020
8/6/2020
34.56-2.16-8.64NA
Q1 2020
5/7/2020
27.36-4.32-17.28NA
Q4 2019
3/11/2020
28.92-1.20-4.80NA
Q3 2019
11/14/2019
36.24-0.84-3.36NA
Q2 2019
8/8/2019
42.48-1.32-5.28NA
Q1 2019
5/9/2019
57.84-1.56-6.24NA
Q4 2018
3/18/2019
68.40-2.16-8.64NA
Q3 2018
11/13/2018
46.32-2.04-8.16NA
Q2 2018
8/9/2018
50.88-2.28-9.12NA
Q1 2018
5/11/2018
42.00-1.44-5.76NA
Q4 2017
4/2/2018
51.60-1.32-5.28NA
Q3 2017
11/6/2017
13.80-1.44-5.76NA
Q2 2017
8/14/2017
7.02-1.68-6.72NA
Q1 2017
5/9/2017
9.84-2.28-9.12NA
Q4 2016
3/14/2017
9.72-2.16-8.64NA
Q3 2016
11/8/2016
47.88-8.40-33.60NA
Q2 2016
8/15/2016
48.12-4.92-19.68NA
Avalo Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q2 2023
8/3/2023
0.20-0.59-2.14NA
Q1 2023
5/4/2023
2.82-0.85-2.93NA
Q4 2022
3/29/2023
1.61-1.04-4.48NA
Q3 2022
11/7/2022
6.700.34-5.36NA
Q2 2022
8/4/2022
4.05-1.38-7.74NA
Q1 2022
5/5/2022
3.96-2.40-8.52NA
Q4 2021
3/2/2022
9.37-1.92-9.96NA
Q3 2021
11/9/2021
27.84-2.04-10.32NA
Q2 2021
8/2/2021
32.28-2.16-10.20NA
Q1 2021
5/13/2021
27.00-3.84-10.20NA
Q4 2020
3/8/2021
36.72-2.28-10.68NA
Q3 2020
11/9/2020
24.72-1.92-9.60NA
Q2 2020
8/6/2020
34.56-2.16-8.52NA
Q1 2020
5/7/2020
27.36-4.32-7.68NA
Q4 2019
3/11/2020
28.92-1.20-4.92NA
Q3 2019
11/14/2019
36.24-0.84-5.88NA
Q2 2019
8/8/2019
42.48-1.32-7.08NA
Q1 2019
5/9/2019
57.84-1.56-8.04NA
Q4 2018
3/18/2019
68.40-2.16-7.92NA
Q3 2018
11/13/2018
46.32-2.04-7.08NA
Q2 2018
8/9/2018
50.88-2.28-6.48NA
Q1 2018
5/11/2018
42.00-1.44-5.88NA
Q4 2017
4/2/2018
51.60-1.32-6.72NA
Q3 2017
11/6/2017
13.80-1.44-7.56NA
Q2 2017
8/14/2017
7.02-1.68-14.52NA
Q1 2017
5/9/2017
9.84-2.28-17.76NA
Q4 2016
3/14/2017
9.72-2.16NANA
Q3 2016
11/8/2016
47.88-8.40NANA
Q2 2016
8/15/2016
48.12-4.92NANA
Quotes delayed 20 minutes

Email EnvelopeFree AVTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Avalo Therapeutics (AVTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

AVXL PE Ratio History
AWH PE Ratio History
AXDX PE Ratio History
AXGN PE Ratio History
AXLA PE Ratio History
AXNX PE Ratio History
AXSM PE Ratio History
AYTU PE Ratio History
AZRX PE Ratio History
AZYO PE Ratio History
How should the AVTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Avalo Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this AVTX Historical PE Ratio page.

What is the average historical PE for AVTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The AVTX historical PE ratio using the annualized quarterly earnings method works out to 4.9.

What is the average historical PE for AVTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The AVTX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Avalo Therapeutics Historical PE Ratio information for Avalo Therapeutics' stock. The average AVTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 4.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average AVTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this AVTX historical PE result, against the recent PE: when this page was posted on 9/27/2023, the most recent closing price for AVTX had been 0.17, and the most recent quarterly earnings result, annualized, was 1.36. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent AVTX PE on 9/27/2023 based on annualized quarterly EPS was 0.1. Based on AVTX's history, that recent PE is low relative to the historical average, with the recent PE 98.0% lower than the historical average PE across our data set for Avalo Therapeutics.

For self directed investors doing their due diligence on AVTX or any other given stock, valuation analysis for AVTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Avalo Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for AVTX. Thanks for visiting, and the next time you need to research AVTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ASCMA Historical Stock Prices, Institutional Holders of PRVA, Top Ten Hedge Funds Holding IRMP.

 

Avalo Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.1%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.1%.